MCKESSON CORP
MCKNYSE🏆 #134 by market capEarnings Nov 4US Equity
$960.56▼ $6.48 (−0.67%)
Market closed · at closeTrack MCK
Get earnings, price moves & breaking news on Telegram
24h▼ 0.7%
7d▼ 5.1%
14d▼ 3.8%
30d▲ 11.1%
ytd▲ 17.1%
1y▲ 18.9%
🏦Market Cap
$111.99B
Mid Cap
📈Revenue Growth (YoY)
8.8%
Slowing
📊Gross Margin
3.6%
Thin
💵FCF Margin
1.6%
Thin
⚖️P/S Ratio
0.3x
Cheap
Otter Score
72
Strong
MCKESSON CORP
MCKAnalyst Ratings
Price
$960.56
Total
31
Raised
3
Lowered
2
Avg PT
$983.13
H / L
$1200 / $845
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Mizuho | Reiterated | Neutral | 2026-10-20 | — | — |
UBS | Reiterated | Buy | 2026-10-16 | $1200.00 | +24.90% |
Leerink Partners | Reiterated | Outperform | 2026-10-07 | $1085.00 | +13.00% |
RBC Capital | Reiterated | Sector Perform | 2026-09-14 | $845.00 | −12.00% |
Barclays | Reiterated | Overweight | 2026-08-19 | $1000.00 | +4.10% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-11 | $933.00 | −2.90% |
TD Cowen | Reiterated | Buy | 2026-08-06 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-08-06 | — | — |
Citigroup | Reiterated | Buy | 2026-07-24 | — | — |
JP Morgan | Reiterated | Overweight | 2026-05-08 | — | — |
B of A Securities | Reiterated | Buy | 2026-04-06 | — | — |
Morgan Stanley | Reiterated | Overweight | 2025-11-06 | $977.00 | +1.70% |
Baird | Reiterated | Outperform | 2025-11-06 | — | — |
Jefferies | Reiterated | Buy | 2025-10-14 | $900.00 | −6.30% |
Deutsche Bank | Reiterated | Buy | 2025-09-24 | $875.00 | −8.90% |
Argus Research | Reiterated | Buy | 2024-06-24 | $670.00 | −30.20% |
Credit Suisse | Reiterated | Outperform | 2023-08-11 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-04-18 | — | — |
Goldman Sachs | Reiterated | Buy | 2021-05-07 | $257.00 | −73.20% |
Guggenheim | Reiterated | Buy | 2020-05-27 | — | — |
CFRA | Reiterated | Buy | 2020-05-20 | — | — |
Standpoint Research | Upgraded | Hold → Buy | 2018-07-10 | — | — |
Leerink Swann | Reiterated | Market Perform | 2018-05-29 | — | — |
Bank of America | Reiterated | Buy | 2018-04-11 | — | — |
Needham | Reiterated | Hold | 2017-04-04 | — | — |
Avondale Partners | Upgraded | Market Perform → Market Outperform | 2017-01-18 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2016-01-12 | $970.00 | +1.00% |
S&P Capital IQ | Downgraded | Strong Buy → Buy | 2014-01-13 | — | — |
FBR Capital | Reiterated | Outperform | 2013-10-29 | — | — |
ISI Group | Upgraded | Buy → Strong Buy | 2013-10-24 | — | — |
Sterne Agee | Reiterated | Buy | 2013-09-18 | — | — |
Institution
Mizuho
Reiterated · Neutral · 2026-10-20
—
—
UBS
Reiterated · Buy · 2026-10-16
$1200.00
+24.90%
Leerink Partners
Reiterated · Outperform · 2026-10-07
$1085.00
+13.00%
RBC Capital
Reiterated · Sector Perform · 2026-09-14
$845.00
−12.00%
Barclays
Reiterated · Overweight · 2026-08-19
$1000.00
+4.10%
Wells Fargo
Reiterated · Equal Weight · 2026-08-11
$933.00
−2.90%
TD Cowen
Reiterated · Buy · 2026-08-06
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-08-06
—
—
Citigroup
Reiterated · Buy · 2026-07-24
—
—
JP Morgan
Reiterated · Overweight · 2026-05-08
—
—
B of A Securities
Reiterated · Buy · 2026-04-06
—
—
Morgan Stanley
Reiterated · Overweight · 2025-11-06
$977.00
+1.70%
Baird
Reiterated · Outperform · 2025-11-06
—
—
Jefferies
Reiterated · Buy · 2025-10-14
$900.00
−6.30%
Deutsche Bank
Reiterated · Buy · 2025-09-24
$875.00
−8.90%
Argus Research
Reiterated · Buy · 2024-06-24
$670.00
−30.20%
Credit Suisse
Reiterated · Outperform · 2023-08-11
—
—
Cowen & Co.
Reiterated · Outperform · 2022-04-18
—
—
Goldman Sachs
Reiterated · Buy · 2021-05-07
$257.00
−73.20%
Guggenheim
Reiterated · Buy · 2020-05-27
—
—
CFRA
Reiterated · Buy · 2020-05-20
—
—
Standpoint Research
Upgraded · Hold → Buy · 2018-07-10
—
—
Leerink Swann
Reiterated · Market Perform · 2018-05-29
—
—
Bank of America
Reiterated · Buy · 2018-04-11
—
—
Needham
Reiterated · Hold · 2017-04-04
—
—
Avondale Partners
Upgraded · Market Perform → Market Outperform · 2017-01-18
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2016-01-12
$970.00
+1.00%
S&P Capital IQ
Downgraded · Strong Buy → Buy · 2014-01-13
—
—
FBR Capital
Reiterated · Outperform · 2013-10-29
—
—
ISI Group
Upgraded · Buy → Strong Buy · 2013-10-24
—
—
Sterne Agee
Reiterated · Buy · 2013-09-18
—
—
One row per institution · price target from the firm's latest published target